Biotech Extremes Asymmetry

Definition

Framework that biotech returns are highly dispersed because the core technology usually fails, so a few big winners drive outcomes and investors need specialized diligence and diversification.

Cast within

No topic-region cast yet — this appears once Biotech Extremes Asymmetry's compiled claims are aligned into a topic region's argument tree.

Claims mentioning Biotech Extremes Asymmetry (2)

Your notes

Loading notes...